The Future of Diagnostics and Laboratory Interoperability

Across Irish healthcare, laboratory data continues to sit at the centre of clinical decision-making. Yet in many settings, lack of laboratory interoperability means data still moves too slowly, too manually, and with too much friction. 

At DMF Systems, much of our work focuses on the practical reality of how diagnostic information flows between laboratories, hospitals and community care. While significant progress has been made over the past decade, many organisations are still managing fragmented systems, partial integrations and manual workarounds that place unnecessary pressure on clinical and laboratory teams.  

As medical scientists are only too aware, there is a real person behind each sample. Patients waiting for important results that are required as soon as possible to shape the next step in their care delivery.  

What is becoming increasingly clear is that diagnostics is moving into a new phase. Expectations around speed, visibility and interoperability are rising quickly, and the underlying digital infrastructure will need to keep pace. 

The question is no longer whether change is coming. It is whether our current systems are ready to support what comes next. 

Diagnostics Is Entering a New Phase 

Diagnostics is not simply evolving incrementally. The scale and speed of change now underway represents a step shift in how laboratory services will operate over the coming decade. What has historically been a largely centralised, laboratory-bound model is becoming more distributed, more automated and more dependent on secure, high-quality data exchange across organisational boundaries. 

Several developments are beginning to reshape the diagnostic landscape in a meaningful way. 

AI-supported testing and laboratory automation are starting to reduce turnaround times and improve consistency across laboratory environments. As these capabilities mature, they will depend heavily on structured, reliable data flows between systems. 

At the same time, point-of-care and decentralised diagnostics are bringing testing closer to the patient. This shift supports faster clinical decisions and improved access, particularly in community and ambulatory settings. However, it also introduces new operational complexity. Results generated outside the core laboratory must still flow securely into the patient record and be visible to the wider care team. Without strong laboratory interoperability integration foundations, decentralisation risks adding fragmentation rather than reducing it.  

Genomics and multi-omics are also advancing rapidly, particularly in oncology, rare disease and personalised medicine. These data sets are significantly more complex than traditional laboratory results. They require systems capable of handling higher data volumes, richer clinical context, and longitudinal patient views that extend beyond single episodes of care. 

Alongside these clinical developments, the European Health Data Space (EHDS) is moving interoperability from policy ambition to regulatory expectation. Current timelines indicate that cross-border exchange of laboratory results across EU member states is expected to come into force by March 2031. This will require robust standards for adoption, clear consent management and secure data exchange at scale across national boundaries.  

Taken together, these shifts point to a healthcare environment that will be far more connected and data-dependent than the one many organisations are operating in today. 

The Infrastructure Question 

These developments naturally lead to a practical concern. Healthcare systems will only realise the benefits of next-generation diagnostics if the underlying information flows are fit for purpose. 

In many environments, laboratories and clinical systems remain connected through point-to-point interfaces, bespoke integrations, or manual processes that have grown over time. While these approaches may continue to function in the short term, they are unlikely to support the scale, speed, and cross-organisational visibility that future models of care demand. 

The impact is not abstract. When diagnostic data is delayed, duplicated or incomplete, the consequences are felt directly in clinical workflows. Discharge decisions are slowed. Repeat testing increases. Clinicians spend more time validating information and less time acting on it. Most importantly, the patient behind the sample is left waiting.  

From a system perspective, this also affects patient flow and operational efficiency. Healthcare systems only move as quickly as the information that supports them.  

This is the space DMF Systems has focused on for more than two decades. Solutions such as MediBRIDGE support secure, structured laboratory messaging across the health system, while LIS2LIS enables direct laboratory interoperability between lab information systems without requiring wholesale platform change. These types of integration layers help organisations strengthen information flow while ameliorating existing investments. 

Why Laboratory Interoperability Matters

For many years, DMF Systems has focused on improving how diagnostic information moves securely and reliably across the health system. Platforms such as MediBRIDGE automate and secure the exchange of laboratory messages, while LRRv4 provides authorised clinicians with access to current and historical laboratory results, supporting cumulative reporting and trend visibility. At a broader clinical level, the GeneCIS Clinical Portal supports longitudinal visibility of the patient record across the care journey. 

This type of foundational work often happens quietly in the background, but it becomes increasingly important as the diagnostic environment evolves. 

AI-supported services depend on clean, structured and timely data. Point-of-care testing depends on reliable upstream integration into hospital and community records. Genomic services depend on the ability to view patient information longitudinally rather than in isolation. EHDS will depend on genuine interoperability supported by standards-based exchange. 

None of these developments will deliver their intended value if diagnostic information remains siloed or dependent on manual intervention. 

Preparing for the Future

The direction of travel is becoming clearer each year. Diagnostics will become more distributed, more data-intensive, and more tightly embedded in routine clinical decision-making. 

For health systems and laboratory leaders, the immediate priority is not simply adopting new diagnostic technologies. Equal attention must be given to the digital infrastructure beneath them to ensure laboratory interoperability. Systems must be able to support scale, speed, secure exchange and cross-system collaboration as standard. 

This does not necessarily require wholesale system replacement. In many cases, meaningful progress can be achieved by strengthening interoperability, improving data flows, and reducing manual hand-offs that introduce delay and risk. 

What matters most is creating an environment where diagnostic information can move once, move securely and be trusted wherever it is accessed. 

This principle continues to guide DMF’s work across laboratory communications and clinical information systems, where the focus remains on practical interoperability that supports clinicians without adding complexity. 

Looking Ahead 

Healthcare only moves as fast as its diagnostic information. When that information flows securely, quickly and in a structured way, the benefits are seen in patient outcomes clinical confidence, and overall system performance. 

Ireland has made important progress in digital health, and there is strong alignment across policy, clinical and technical communities on the direction ahead. The next phase will depend on continued focus on the fundamentals of connectivity, data quality, and clinical and laboratory interoperability. 

Organisations that invest now in connected diagnostic infrastructure will be better placed to support the next stage of digital health across Ireland and to meet emerging EU requirements in the years ahead. 

Get in touch today to assess your laboratory interoperability readiness and learn more about your options.

Frequently Asked Questions 

What is changing in the future of diagnostics? 
Diagnostics is becoming more distributed, data-intensive, and technology-enabled. Advances in automation, point-of-care testing, genomics, and EU-wide data initiatives such as EHDS are increasing the demand for secure, interoperable diagnostic infrastructure. 

Why is interoperability important for laboratory systems? 
Interoperability ensures that laboratory results can move securely and reliably between systems and care settings. Without it, clinicians may face delays, duplicate testing, and incomplete patient information. 

How can laboratories reduce diagnostic turnaround time? 
Turnaround time can be improved by automating laboratory workflows, reducing manual data entry, and ensuring results move electronically between systems without delay. 

What does the European Health Data Space mean for Irish healthcare? 
EHDS will require EU member states to support secure, standards-based exchange of health data across borders. For laboratories, this increases the importance of structured data, consent management, and true system interoperability ahead of the 2031 timeline. 

Why is longitudinal visibility of lab results important? 
Access to historical and cumulative lab results allows clinicians to identify trends, reduce duplicate testing, and make more informed clinical decisions over time. 

How do point-of-care results integrate into hospital systems? 
Point-of-care results must flow through secure messaging and integration layers into the patient record. Without this, decentralised testing can create new information gaps rather than improving care.